Advertisement
Central Surgical Association| Volume 128, ISSUE 4, P531-539, October 2000

Download started.

Ok

A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism

      Abstract

      Background. To assess the impact of surgery on preoperative symptoms in secondary (2°) and tertiary (3°) hyperparathyroidism (HPT) compared with primary (1°) HPT. Methods. Twenty-two patients with 2° HPT and 10 with 3° HPT were enrolled. Age-matched patients, 32 with 1° HPT and 32 with thyroid disease were enrolled for comparison. An outcome questionnaire documented symptoms expressed as the median symptom index score (MSIS) preoperatively and at days 7 and 3 and 12 months postoperatively. Results. Preoperatively, the MSIS for the groups with 3°, 2°, and 1° HPT and thyroid disease was 225, 572, 372, and 146, indicating that patients with HPT were more symptomatic than those in the thyroid group (P <.05). Patients with 1° HPT had a decrease in their MSIS at day 7 (195, P <.05) and at 3 and 12 months (159 and 156). Patients with 3° HPT also had a decrease in their MSIS over time. Patients with 2° HPT had a decrease in their MSIS at day 7 (469, P <.05); however, they remained more symptomatic at 3 and 12 months (410 and 355). Conclusions. Parathyroidectomy reduces many of the preoperative symptoms in HPT. Patients with 1° and 3° HPT have a similar resolution of their symptoms. Patients with 2° HPT have an improvement in many of their symptoms, although they remain more symptomatic at 1 year. (Surgery 2000;128:531-9.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Packman KS
        • Demeure MJ
        Indications for parathyroidectomy and extent of treatment for patients with secondary hyperparathyroidism.
        Surg Clin North Am. 1995; 75: 465-482
        • Bleyer AJ
        • Choi M
        • Igwemezie B
        • de la Torre E
        • White WL
        A case control study of proximal calciphylaxis.
        Am J Kidney Dis. 1998; 32: 376-383
        • Chou FF
        • Ho JC
        • Huang SC
        • Sheen-Chen SM
        A study on pruritus after parathyroidectomy for secondary hyperparathyroidism.
        J Am Coll Surg. 2000; 190: 65-70
        • Demeure MJ
        • McGee DC
        • Wilkes W
        • Duh QY
        • Clark OH
        Results of surgical treatment for hyperparathyroidism associated with renal disease.
        Am J Surg. 1990; 160: 337-340
        • Rothmund M
        • Wagner PK
        • Schark C
        Subtotal parathyroidectomy verus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial.
        World J Surg. 1991; 15: 745-750
        • Hampl H
        • Steinmuller T
        • Frohling P
        • Naoum C
        • Leder K
        • Stabell U
        • et al.
        Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure.
        Miner Electrolyte Metab. 1999; 25: 161-170
        • Pasieka JL
        • Parsons L
        Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism.
        World J Surg. 1998; 22: 513-519
        • Pasieka JL
        • Parsons L
        A retrospective analysis on the change in symptoms resulting from hyperparathyroidism following surgical intervention; allowing for the validation of a prospective surgical outcome study questionnaire (abstract).
        World Congress of Surgery. 1995; 338: 83
        • Guyatt G
        • Bonbardier C
        • Tugwell P
        Measuring disease specific quality of life in clinical trials.
        Can Med Assoc J. 1986; 134: 889-895
        • Bergner M
        Measurement of health status.
        Med Care. 1985; 23: 696-704
        • Stein MS
        • Packham DK
        • Wark JD
        • Becker GJ
        Response to parathyroidectomy at the axial and appendicular skeleton in renal patients.
        Clin Nephrol. 1999; 52: 172-178
        • Hampers CL
        • Katz AL
        • Wilson RE
        • Merril JP
        Disappearance of uremic itching after subtotal parathyroidectomy.
        N Engl J Med. 1968; 296: 1575-1580
        • Deutch SR
        • Jensen MB
        • Christiansen PM
        • Hessov I
        Muscular performance and fatigue in primary hyperparathyroidism.
        World J Surg. 2000; 24: 102-107
        • Chou FF
        • Lee CH
        • Chen JB
        General weakness as an indication for parathyroid surgery in patients with secondary hyperparathyroidism.
        Arch Surg. 1999; 134: 1108-1111
        • Colliander EB
        • Strigard K
        • Westblad P
        • Rolf C
        • Nordenstrom J
        Muscle strength and endurance after surgery for primary hyperparathyroidism.
        Eur J Surg. 1998; 164: 489-494
        • Silverberg SJ
        • Bilezikian JP
        • Bone HG
        • Talpos GB
        • Horwitz MJ
        • Stewart AF
        Therapeutic controversies in primary hyperparathyroidism.
        J Clin Endocrinol Metab. 1999; 84: 2275-2285
        • Burney RE
        • Jones KR
        • Peterson M
        • Chirsty B
        • Thompson NW
        Surgical correction of primary hyperparathyroidism improves quality of life.
        Surgery. 1998; 124: 987-992
        • Okamoto T
        • Gerstein HC
        • Obara T
        Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism; a systematic overview of the literature.
        Endocr J. 1997; 44: 367-374